Literature DB >> 20166818

Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States.

Carlos G Grijalva1, J Pekka Nuorti, Yuwei Zhu, Marie R Griffin.   

Abstract

BACKGROUND: The incidence of childhood pneumonia decreased following introduction of 7-valent pneumococcal conjugate vaccine (PCV7) in the United States. Recent regional reports suggest an increase in the incidence of childhood pneumonia complicated by empyema. We assessed whether early decreases in pneumonia hospitalization rates were sustained and trends in such hospitalizations complicated by empyema in United States children aged <5 years.
METHODS: Nationwide Inpatient Sample and Census data were used to calculate annual all-cause and pneumococcal pneumonia hospitalization rates for pre-PCV7 (1996-1999) and post-PCV7 years (2001-2007) and to analyze national trends in total and pathogen-specific pneumonia-associated empyema.
RESULTS: Among children aged <2 years, all-cause pneumonia hospitalizations decreased 33% (95% confidence interval, 28%-37%) from 1267 cases per 100,000 children in pre-PCV7 years to 852 cases per 100,000 children in post-PCV7 years. Pneumococcal pneumonia hospitalization rates decreased 61% (95% confidence interval, 55%-67%) post-PCV7, compared with pre-PCV7 years. Pneumonia hospitalizations complicated by empyema increased 2.01-fold from 3.5 cases per 100,000 children in 1996-1998 to 7.0 cases per 100,000 children in 2005-2007. Rates of pneumococcal and streptococcal empyema remained stable, whereas rates of staphylococcal and other or unspecified empyema increased 4.08- and 1.89-fold, respectively. Among children aged 2-4 years, all-cause pneumonia rates remained stable, whereas pneumococcal pneumonia decreased by 26% (95% confidence interval, 16-34). Pneumonia complicated by empyema increased 2.81-fold from 3.7 cases per 100,000 children in 1996-1998 to 10.3 cases per 100,000 children in 2005-2007. In this age group, there were 2.17-, 2.80-, 3.76-, and 3.09-fold increases in rates of pneumococcal, streptococcal, staphylococcal, and other or unspecified empyema, respectively.
CONCLUSION: Decreases in childhood pneumonia hospitalization rates following PCV7 introduction were sustained. Although empyema complicated only a small fraction of pneumonia hospitalizations, its prevalence increased substantially. This increase was due to several pathogens and warrants continuing monitoring.

Entities:  

Mesh:

Year:  2010        PMID: 20166818      PMCID: PMC4696869          DOI: 10.1086/650573

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  33 in total

1.  Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Scott A Harper; Keiji Fukuda; Timothy M Uyeki; Nancy J Cox; Carolyn B Bridges
Journal:  MMWR Recomm Rep       Date:  2004-05-28

2.  Streptococcus pneumoniae thoracic empyema in children: rapid diagnosis by using the Binax NOW immunochromatographic membrane test in pleural fluids.

Authors:  C Ploton; A M Freydiere; Y Benito; N Bendridi; C Mazzocchi; G Bellon; F Vandenesch
Journal:  Pathol Biol (Paris)       Date:  2006-10-05

3.  An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations.

Authors:  Carrie L Byington; LaShonda Y Spencer; Timothy A Johnson; Andrew T Pavia; Daniel Allen; Edward O Mason; Sheldon Kaplan; Karen C Carroll; Judy A Daly; John C Christenson; Matthew H Samore
Journal:  Clin Infect Dis       Date:  2002-01-03       Impact factor: 9.079

4.  Influenza vaccination coverage among children aged 6-23 months--United States, 2006-07 influenza season.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-09-26       Impact factor: 17.586

5.  Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults.

Authors:  Jennifer C Nelson; Michael Jackson; Onchee Yu; Cynthia G Whitney; Lora Bounds; Rachel Bittner; Ann Zavitkovsky; Lisa A Jackson
Journal:  Vaccine       Date:  2008-07-26       Impact factor: 3.641

6.  Clinical features, aetiology and outcome of empyema in children in the north east of England.

Authors:  K M Eastham; R Freeman; A M Kearns; G Eltringham; J Clark; J Leeming; D A Spencer
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

7.  Influenza-associated hospitalizations in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

8.  Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine.

Authors:  Aviv D Goldbart; Eugene Leibovitz; Nurith Porat; Noga Givon-Lavi; Ido Drukmann; Asher Tal; David Greenberg
Journal:  Scand J Infect Dis       Date:  2009

9.  Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.

Authors:  Carlos G Grijalva; J Pekka Nuorti; Patrick G Arbogast; Stacey W Martin; Kathryn M Edwards; Marie R Griffin
Journal:  Lancet       Date:  2007-04-07       Impact factor: 79.321

10.  Pediatric parapneumonic empyema, Spain.

Authors:  Ignacio Obando; Carmen Muñoz-Almagro; Luis A Arroyo; David Tarrago; David Sanchez-Tatay; David Moreno-Perez; Sahar S Dhillon; Cristina Esteva; Susanna Hernandez-Bou; Juan J Garcia-Garcia; William P Hausdorff; Angela B Brueggemann
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

View more
  56 in total

1.  National hospitalization trends for pediatric pneumonia and associated complications.

Authors:  Grace E Lee; Scott A Lorch; Seth Sheffler-Collins; Matthew P Kronman; Samir S Shah
Journal:  Pediatrics       Date:  2010-07-19       Impact factor: 7.124

2.  Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era.

Authors:  Krow Ampofo; Andrew T Pavia; Chris R Stockmann; Anne J Blaschke; Hsin Yi Cindy Weng; Kent E Korgenski; Judy Daly; Carrie L Byington
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

3.  Establishing Equipoise: National Survey of the Treatment of Pediatric Para-Pneumonic Effusion and Empyema.

Authors:  Morgan K Richards; Jarod P Mcateer; Todd C Edwards; Lucas R Hoffman; Matthew P Kronman; Dennis W Shaw; Adam B Goldin
Journal:  Surg Infect (Larchmt)       Date:  2016-11-29       Impact factor: 2.150

4.  Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children.

Authors:  Naïm Ouldali; Corinne Levy; Philippe Minodier; Laurence Morin; Sandra Biscardi; Marie Aurel; François Dubos; Marie Alliette Dommergues; Ellia Mezgueldi; Karine Levieux; Fouad Madhi; Laure Hees; Irina Craiu; Chrystèle Gras Le Guen; Elise Launay; Ferielle Zenkhri; Mathie Lorrot; Yves Gillet; Stéphane Béchet; Isabelle Hau; Alain Martinot; Emmanuelle Varon; François Angoulvant; Robert Cohen
Journal:  JAMA Pediatr       Date:  2019-04-01       Impact factor: 16.193

5.  Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema.

Authors:  Anne J Blaschke; Caroline Heyrend; Carrie L Byington; Ignacio Obando; Isabel Vazquez-Barba; Elizabeth H Doby; E Kent Korgenski; Xiaoming Sheng; Mark A Poritz; Judy A Daly; Edward O Mason; Andrew T Pavia; Krow Ampofo
Journal:  Pediatr Infect Dis J       Date:  2011-04       Impact factor: 2.129

6.  Emergence of parapneumonic empyema in the USA.

Authors:  Carlos G Grijalva; Yuwei Zhu; J Pekka Nuorti; Marie R Griffin
Journal:  Thorax       Date:  2011-05-26       Impact factor: 9.139

Review 7.  A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children.

Authors:  Carlos G Grijalva; Stephen I Pelton
Journal:  Curr Opin Pediatr       Date:  2011-02       Impact factor: 2.856

8.  Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhood.

Authors:  Samir S Shah; Matthew Hall; Jason G Newland; Thomas V Brogan; Reid W D Farris; Derek J Williams; Gitte Larsen; Bryan R Fine; James E Levin; Jeffrey S Wagener; Patrick H Conway; Angela L Myers
Journal:  J Hosp Med       Date:  2011-03-03       Impact factor: 2.960

Review 9.  Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine.

Authors:  Inci Yildirim; Kimberly M Shea; Stephen I Pelton
Journal:  Infect Dis Clin North Am       Date:  2015-12       Impact factor: 5.982

10.  Surgical management and outcome analysis of stage III pediatric empyema thoracis.

Authors:  Prema Menon; K L N Rao; Meenu Singh; M A Venkatesh; R P Kanojia; R Samujh; A K Saxena; Y K Batra
Journal:  J Indian Assoc Pediatr Surg       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.